Reproductive autonomy is the principle that the decision to have or not have children, with whom, and under what conditions, belongs to the person whose body and life will be most affected. The principle is broadly endorsed in liberal democracies and broadly violated in practice. The next two decades of reproductive policy fights will be fought across an expanded battlefield that includes the older question of abortion access, the newer questions of embryo selection and germline editing, the emerging questions of in vitro gametogenesis and uterine transplantation, and the persistent questions of who can access reproductive services and on what terms.
The reversal of Roe v. Wade in 2022 made clear that reproductive autonomy in the United States is not a stable settlement but a contested terrain. State-by-state divergence has produced a patchwork in which the same pregnancy is differently legible depending on the zip code. The consequences extend beyond abortion access to IVF, where the legal status of embryos in some states now creates uncertainty about routine clinical practice, and to maternal medicine, where the management of complications has become legally fraught. The policy fights are not isolated; they are connected nodes in a single contest over who decides about reproduction.
The international landscape is similarly fragmented. Some countries have moved toward expansion of reproductive autonomy—Ireland's repeal of its abortion ban, Argentina's legalization, expanded fertility funding in parts of Europe. Others have moved toward restriction—Poland's tightening, parts of the United States, parts of Latin America that have not followed Argentina. The fights are not converging toward a global norm; they are diverging along political lines that map onto broader contests between liberalization and traditionalism.
The think and connect laws are implicated because the policy debates are often conducted in framings that obscure the underlying questions. "Pro-life" and "pro-choice" labels have organized U.S. discourse for fifty years and have become unhelpfully calcified. The actual policy questions are more granular: at what gestational age does state interest in fetal life become weighty, what exceptions for maternal health and fetal anomaly are required, what role should public funding play in access, what is the appropriate regulation of IVF embryos that the same legal framework may now categorize as persons. Each granular question has answers that don't fall cleanly along the binary, and most polled publics hold positions more nuanced than the political coalitions representing them.
The fights ahead also include questions that did not exist when the current frameworks were built. Polygenic embryo selection regulation. Germline editing prohibition or licensing. The legal status of in vitro-derived gametes. Parental rights in multi-parent and same-sex genetic configurations. Gestational surrogacy across borders. The right to know one's donor origin. The protection of biological samples from non-consensual reproductive use. Each is a substantive policy question that requires deliberation, and each is being shaped now by the absence of deliberation as much as by its presence.
Dorothy Roberts's framing of reproductive justice—as distinct from but encompassing reproductive autonomy—insists that the questions cannot be reduced to individual choice. The choices a person can actually make depend on the resources, support structures, and freedom from coercion that surround them. A society that prohibits abortion while also providing inadequate childcare, parental leave, healthcare for pregnant people, and economic support for parents is not protecting reproductive autonomy but constraining it. A society that subsidizes fertility services for some populations while sterilizing or surveilling the reproduction of others is not neutral about reproduction. The policy fights ahead are not only about specific procedures but about the entire infrastructure that makes reproductive choice meaningful or hollow.
The plan law is implicated because the next round of policy will be built or not built deliberately. The reproductive technologies emerging now—polygenic selection, germline editing, in vitro gametogenesis, uterine transplantation—will be regulated by frameworks that either anticipate their implications or scramble to catch up. The revise law is implicated because existing frameworks were built for technologies of the 1970s and 1980s. The frameworks that emerge in the next decade will shape the experiences of children born across the next half-century. The collective task is to engage now with the questions that will otherwise be answered by default through the accumulated decisions of clinics, courts, and markets.
The honest reading of the policy landscape is that the fights are not winnable in single battles. Reproductive autonomy is a continuously contested space in which the gains and losses of any given decade are partial and reversible. The work is to expand the space of meaningful choice, to defend access where it exists, to extend it where it doesn't, and to recognize that the fight is not about a final settlement but about the ongoing maintenance of the conditions under which reproduction can be a domain of human agency rather than of state, market, or familial coercion.